Tactile Systems Technology, Inc. reported a 4% increase in total revenue to $61.1 million for the first quarter of 2024, driven by a 5% increase in lymphedema product revenue. The company's net loss was $2.2 million, while adjusted EBITDA improved to $1.0 million.
Total revenue increased 4% year-over-year to $61.1 million.
Lymphedema product revenue increased 5% year-over-year.
Airway clearance product revenue decreased 4% year-over-year.
Net loss of $2.2 million compared to $1.9 million in the same quarter last year.
The Company continues to expect full year 2024 total revenue in the range of $300 million to $305 million, representing growth of approximately 9% to 11% year-over-year, compared to total revenue of $274.4 million in 2023.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance